SAN
83.79
-1.38%↓
SHL.DE
43.52
+0.3%↑
ARGX
784.6
+1.92%↑
PHIA
23.46
+0.56%↑
ONC.US
322.59
-2.5%↓
SAN
83.79
-1.38%↓
SHL.DE
43.52
+0.3%↑
ARGX
784.6
+1.92%↑
PHIA
23.46
+0.56%↑
ONC.US
322.59
-2.5%↓
SAN
83.79
-1.38%↓
SHL.DE
43.52
+0.3%↑
ARGX
784.6
+1.92%↑
PHIA
23.46
+0.56%↑
ONC.US
322.59
-2.5%↓
SAN
83.79
-1.38%↓
SHL.DE
43.52
+0.3%↑
ARGX
784.6
+1.92%↑
PHIA
23.46
+0.56%↑
ONC.US
322.59
-2.5%↓
SAN
83.79
-1.38%↓
SHL.DE
43.52
+0.3%↑
ARGX
784.6
+1.92%↑
PHIA
23.46
+0.56%↑
ONC.US
322.59
-2.5%↓
24h
Actuel
Min
119.1
Max
120.5
Revenu | 250M 902M |
|---|---|
Ventes | 63M 5.3B |
BPA | 2.07 |
Rendement du dividende | 1.34 |
Marge bénéficiaire | 16.961 |
Recommandations | Achat |
|---|---|
Prévisions sur 12 Mois | +17.11% upside |
Rendement du dividende Moyenne du Secteur | 1.34% 2.29% |
|---|
Capitalisation Boursière | 98B |
|---|---|
Ouverture précédente | 120.41 |
Clôture précédente | 120 |
By Acuity
10%
90%
7 / 374 Classement par Healthcare
By Trading Central
Confiance
Strong Bearish Evidence
121.15 / 123.55 Support & Résistance
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
13 nov. 2025, 13:40 UTC
Germany's Merck KGaA Shares Rise After Semiconductor, Pharma Demand Boost Results -- Update
DJ
Lire
13 nov. 2025, 06:24 UTC
Germany's Merck KGaA Posts Higher Earnings on Organic Growth Across Units
DJ
Lire
1 oct. 2025, 08:54 UTC
Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site
DJ
Lire
13 nov. 2025, 07:57 UTC
Germany's Merck KGaA Beats Expectations With Strong Results -- Market Talk
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Sees 2025 Ebitda Before Exceptional Items at EUR6B-EUR6.2B
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Narrows 2025 View To Sales EUR20.8B-EUR21.4B
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Sees 2025 Organic Ebitda Before Exceptional Items Growth of 5%-7%
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Had Guided for 2025 Organic Sales Growth of 2% to 5%
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Says Guidance Midpoint Remains Unchanged
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Had Guided for 2025 Organic Ebitda Before Exceptional Items Growth of 4%-8%
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Sees 2025 Organic Sales Growth of Around 3%
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA 3Q After-Tax Profit EUR898M
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA: 3Q Net Sales Rose 5.2% Organically With Solid Growth Across Sectors
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA Narrows 2025 View
DJ
Lire
13 nov. 2025, 06:00 UTC
Analysts Saw Merck KGaA 3Q Net Sales at EUR5.23B
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA 3Q Ebitda Before Exceptional Items EUR1.67B
DJ
Lire
13 nov. 2025, 06:00 UTC
Analysts Saw Merck KGaA 3Q Ebitda Before Exceptional Items EUR1.56B
DJ
Lire
13 nov. 2025, 06:00 UTC
Merck KGaA 3Q Sales EUR5.32B
DJ
Lire
6 nov. 2025, 21:52 UTC
Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED
DJ
Lire
6 nov. 2025, 21:51 UTC
Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany
DJ
Lire
16 oct. 2025, 08:34 UTC
Merck KGaA's Cost Cutting Likely Led to Profitability Target Raise -- Market Talk
DJ
Lire
15 oct. 2025, 12:08 UTC
Merck KGaA Didn't Disclose Financial Details
DJ
Lire
15 oct. 2025, 12:07 UTC
Merck KGaA: JSR's Amsphere Protein A Resin Tech Complements Existing Biologics Portfolio
DJ
Lire
15 oct. 2025, 12:07 UTC
Merck KGaA: Unit is Based in Belgium, Has 50+ Employees
DJ
Lire
15 oct. 2025, 12:06 UTC
Merck KGaA: Deal Will Strengthen Position in Bioprocessing Market
DJ
Lire
15 oct. 2025, 12:05 UTC
Merck KGaA: Definitive Agreement Signed Today
DJ
Lire
15 oct. 2025, 12:05 UTC
Merck KGaA: Transaction Expected to Close by End of 2Q 2026
DJ
Lire
15 oct. 2025, 12:04 UTC
Merck KGaA to Buy Chromatography Business JSR Life Sciences
DJ
Lire
15 oct. 2025, 12:03 UTC
Merck KGaA to Buy Chromatography Business of JSR Life Sciences
DJ
Lire
7 août 2025, 08:04 UTC
Germany's Merck Misses Expectations on Weaker Electronics Performance -- Market Talk
DJ
Lire
Variation de prix
By TipRanks
Prévisions sur 12 Mois
Moyen 141.29 EUR 17.11%
Haut 182 EUR
Bas 105 EUR
Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.
By TipRanks
Achat
8 ratings
5
Achat
2
Maintien
1
Vente
Basé sur 8 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.
By Trading Central
Court Terme
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Moyen Terme
Neutral Evidence
The bullish and bearish events are balanced.
Long Terme
Bearish Evidence
All events are bearish.
By Acuity
Sentiment de l'Actualité
Très Fortes Indications Haussières
Volatilité
Inférieur à la moyenne
Changement du Volume d'Actualités (RCV)
Inférieur à la moyenne
Frais Généraux et Administratifs
Dépenses d'exploitation
Résultat avant impôt
Ventes
Coût des ventes
Marge brute des ventes
Charges d'intérêt sur la dette
EBITDA
Bénéfice d'exploitation
$